Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK.
| Image |  |
|---|---|
| Description | scientific article published on January 2009 |
| Author/s |
author: Yehuda Carmeli |
| Publication date | January 1, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |